SciencePower is proud to announce that preclinical findings generated by its internal research team will be presented at the upcoming San Antonio Breast Cancer Symposium (SABCS), taking place December 9-12, 2025, as part of our ongoing collaborative program with Mayo Clinic.

The presentation, led by Prof. Roberto Berni Canani, will highlight SciencePower’s proprietary postbiotic composition, developed through our Sequential Fermentation Platform™.

These studies – designed, conducted, and analyzed by SciencePower, examine how defined postbiotic compositions derived from Lactobacillus paracasei interact with immune and cellular pathways relevant to breast cancer biology.

The San Antonio Breast Cancer Symposium® (SABCS) is the world’s leading conference dedicated to advancing scientific understanding and therapeutic innovation in breast cancer, bringing together researchers and clinicians from around the globe.

Join the Conversation

For partnership opportunities or scientific collaboration discussions related to this research, please contact info@sciencepower.com.

We welcome dialogue with research institutions, clinicians, and companies interested in advancing the therapeutic potential of next-generation postbiotics.

Coming Soon